Oppenheimer & Co. Inc. lessened its stake in SPDR S&P Biotech ETF ( NYSEARCA:XBI – Get Rating ) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 86,540 shares of the exchange traded fund's stock after selling 1,875 shares during the quarter. Oppenheimer & Co. Inc. owned approximately 0.10% of SPDR S&P Biotech ETF worth $7,183,000 as of its most recent SEC filing. Several other large investors also recently made changes to their positions in XBI.

https://www.dailypolitical.com/2023/05/05/oppenheimer-co-inc-has-7-18-million-holdings-in-spdr-sp-biotech-etf-nysearcaxbi.html

#dailypolitical